Real-time enrollment status for this sjögren's disease clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:07 PM UTC
| NCT Number | NCT06440525 |
| Recruiting Status | Recruiting |
| Condition | Sjögren's Disease |
| Phase | Clinical Trial |
| Target Enrollment | 106 participants |
| Active Locations | 24 sites in the US |
| Sponsor | Resolve Therapeutics |
| Last Updated on CT.gov | July 18, 2025 (Jul 18, 2025) |
As of March 2, 2026: Clinical trial NCT06440525 is currently recruiting participants. This clinical trial study for sjögren's disease is actively seeking new participants at 24 locations across the United States. The study is sponsored by Resolve Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06440525 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 24 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06440525 was last updated Jul 18, 2025 (July 18, 2025). HelloStudys verifies this status automatically.